Medtronic

 Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon 

cryoballoon ablation clinical studies

 Treatment with ITB Therapy vs. Oral Medication Shows Quality of Life Improvement, Reduction in Spasticity-Related Pain 

ABOUT ITB THERAPY FOR SEVERE SPASTICITY

 Medtronic Announces One-Month DAPT Clinical Study in the U.S. and Japan with Resolute Onyx DES in High Bleeding Risk Patients 

Resolute Onyx(TM) Drug-Eluting Stent (DES)

 Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure 

eartWare(TM) HVAD(TM) System Only LVAD Approved for Implant via Thoracotomy or Median Sternotomy

 Medtronic aims for 4% growth through consolidation, high-tech and direct-to-customer deals

INSTITUTIONAL INVESTOR AND ANALYST MEETING 2018

abbott

 Abbott Receives FDA Approval for Next-Generation MitraClip® Device to Treat People with Leaky Heart Valves

MitraClip®

 Abbott's Tendyne mitral valve shows positive effect in global study

TENDYNE™ DEVICE FOR MITRAL VALVE REPLACEMENT

 NEW COVERAGE DECISION EXTENDS ABBOTT'S INNOVATIVE PAIN THERAPY OPTION TO 22 MILLION AMERICANS LIVING WITH CHRONIC PAIN 

Abbott is the only company in the world with FDA and CE Mark approval to offer dorsal root ganglion (DRG) neurostimulation therapy to treat complex nerve pain conditions

 ABBOTT'S FREESTYLE® LIBRE 14 DAY FLASH GLUCOSE MONITORING SYSTEM NOW APPROVED IN U.S. 

FREESTYLE® LIBRE 14 DAY FLASH GLUCOSE MONITORING SYSTEM

 ABBOTT EXPANDS ITS DIRECTIONAL DEEP BRAIN STIMULATION THERAPY BY OFFERING NEW MR-CONDITIONAL LABELING 

Abbott's Infinity™ DBS system

 ABBOTT INTRODUCES BREAKTHROUGH POINT-OF-CARE TEST, THE M-PIMA™ HIV-1/2 VIRAL LOAD (VL), AT AIDS 2018 AMSTERDAM 

m-PIMA™ HIV-1/2 VIRAL LOAD TEST

Abiomed

 Abiomed Announces Approval in India for the Impella 2.5®, Impella CP® and Impella 5.0® Heart Pumps and First Indian Patient Treate 

Impella 2.5®, Impella CP® and Impella 5.0® Heart Pumps

 Abiomed Receives FDA Approval for Impella CP® with SmartAssist™ and Optical Sensor 

Impella CP® with SmartAssist™ and Optical Sensor

 Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg 

The Impella 5.5 is approved in Europe

 Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock 

Impella 2.5, Impella CP, Impella 5.0, and Impella LD Catheters, in conjunction with the Automated Impella Controller

illumina

 Illumina Receives Approval of MiSeq™Dx System in China

MiSeq™Dx System

 Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology

AmpliSeq for Illumina – a comprehensive targeted resequencing solutio

 Illumina Launches iSeq 100 Sequencing System

iSeq™ 100 Sequencing System

 Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics for Bristol-Myers Squibb’s Oncology Immunotherapies

A Diagnostic Version of the Illumina TruSight™ Oncology 500 Assay Will Measure Potentially Predictive Genomic Biomarkers, Including Tumor Mutation Burden

 

Second quarter 2018 results:

Revenue of $830 million, a 25% increase compared to $662 million in the second quarter of 2017

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2018

 Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

Illumina and Loxo Oncology Join Forces to Develop Pan-Cancer Companion Diagnostics

Intuitive surgical

 Intuitive Surgical Announces Innovative Single Port Platform — the da Vinci SP® Surgical System 

The da Vinci SP system

 Intuitive Submits New Robotic-Assisted Platform to FDA for Obtaining Lung Biopsies 

Da Vinci by Intuitive

 Intuitive Surgical Receives FDA Clearance for First 60mm Stapler 

SureForm 60™, a single-patient use 60mm stapler, offers 120 degrees of fully wristed articulation

 New Study Shows Robotic-Assisted Surgery Benefits for Inguinal Hernia Repair 

da Vinci Surgical System

 New Study Reports Favorable Results for Intuitive Surgical’s Flexible Robotics Platform 

Results from the first clinical study evaluating a new flexible robotics platform under development by Intuitive Surgical

 Intuitive Surgical Receives CE Mark for Latest da Vinci® Robotic-Assisted Surgical System 

Intuitive Surgical Receives CE Mark for Latest da Vinci® Robotic-Assisted Surgical System